Cardiology
CHF
More in CHF
Continued OAC failed to meet noninferiority in POPular PAUSE TAVI
Recent developments of interest in cardiovascular medicine
Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival
NOTION-3 trial informs care for those with severe AS and stable CAD
RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates
Randomized trial "highly encouraging" for making patients feel and function better
Either choice is "acceptable" based on randomized study
RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent
Recent developments of interest in cardiovascular medicine
Recent developments of interest in cardiovascular medicine
Fewer people using primary prevention medications expected to result in more CVD
